HR Execs on the Move

Rsvp and Act Inc

www.4act.com

 
Rsvp & Act Inc is a Denton, TX-based company in the Business Services sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

LeadLander

LeadLander is one of the leading providers in Business Services. It is based in San Francisco, CA. To find more information about LeadLander, please visit www.leadlander.com.

4M Building Solutions

Founded in 1978, 4M Building Solutions is one of the largest janitorial and related facilities services providers in the Midwest and Southeast. 4M Building Solutions is headquartered in St. Louis, MO with more than 3,000 employees servicing over 85 million square feet every daily.

Cognisys

Cognisys is a Spring, TX-based company in the Business Services sector.

Capbizz

Capbizz is a Richmond, VA-based company in the Business Services sector.

Apellis Pharmaceuticals

Apellis Pharmaceuticals is a global biopharmaceutical company based in Waltham, Massachusetts. The company is focused on developing innovative therapies that target the complement system, a crucial part of the immune system. Apellis aims to create life-changing treatments for various debilitating diseases through its commitment to scientific research and patient care. The company has a diverse pipeline of products, including EMPAVELI, which is approved for treating paroxysmal nocturnal hemoglobinuria and is being investigated for other conditions. SYFOVRE is in development for geographic atrophy, along with a combination therapy involving APL-APL-3007. Apellis is also exploring RNA therapies and gene-edited treatments for multiple therapeutic areas. With a global presence in countries such as the US, Canada, and several European nations, Apellis serves patients and healthcare providers affected by diseases related to the complement system. The company reported approximately $709 million in U.S. net product revenues for the full year 2024, reflecting its strong market position and commitment to advancing its therapeutic offerings.